Drug that skyrocketed 5,000% hasn't come down in price

Posted online October 12, 2015 | 11:36 am

The drug that skyrocketed in price from $13.50 to $750 a pill has yet to come back down.

"We've agreed to lower the price of Daraprim to a price that is more affordable," Martin Shkreli, CEO of Turing Pharmaceuticals, said on ABC World News Tonight on Sept. 24. He did not specify a price or timeline.

Used by cancer and AIDS patients, the drug's price increase sparked a public outcry.

Read more from CNNMoney.

Torgerson Design Partners HQ planned at site of collapsed building

Comments

No comments on this story |

Please log in to add your comment

Editors' Pick

From the Ground Up: Willard Central Elementary School safe room and additions

A safe room and classroom addition at Willard Central Elementary School will be used by the music, arts and athletic programs for a district that had 4,536 students last year, according to Missouri Department of Elementary and Secondary Education figures, but school officials say enrollment is projected to grow.

Most Read